Skip to content

Effect of exercise therapy on residual renal function in incident peritoneal dialysis patients

Effect of exercise therapy on residual renal function in incident peritoneal dialysis patients - Effect of exercise therapy on residual renal function in incident peritoneal dialysis patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000039589
Enrollment
64
Registered
2020-02-25
Start date
2020-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease Stage5-D

Interventions

determineed exercise tolerance and optimum home-based exercise therapy. 3times/week non-intervention-controlled

Sponsors

International University of Health and Welfare Graduate School of Medicine
Lead Sponsor
Faculty of medicine, Keio University
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The incident peritonearl dyalisis patients and suit the conditions as below. 1) 30yeas old or more, under 90years old 2) Patients who have been fully informed about participating in this study, have a thorough understanding, and have given their informed consent

Exclusion criteria

Exclusion criteria: Patients who are contraindicated for exercise therapy (specifically the following) 1. Uncontrolled hypertension (>180 systolic blood pressure or >110 mmHg diastolic blood pressure persistent) 2. Severe anemia (Hb under 7 g/dL) 3. Active proliferative diabetic retinopathy 4. Patients with coronary artery disease or cerebrovascular disease within 3 months 5. Uncontrolled heart failure (NYHA III or higher) 6. People who have difficulty walking 7. Others who are not investigators or those who are inappropriate as study subjects

Design outcomes

Primary

MeasureTime frame
residual renal function, rGFR (the mean of Urea and Creatinine clearances)

Secondary

MeasureTime frame
L-FABP, KIM-1, NGAL, Cystatin C, NAG, beta2 MG,micro albumin to creatinine ratio Serum Na/K/Cl,Ca/P/PTH intact,UA, TC/HDL/TG,Hb,HbA1c,FOMA-IR,QOL

Countries

Japan

Contacts

Public ContactNaoki Washida

International University of Health and Welfare Graduate School of Medicine Department of medicine, Clinical research of medicine

naoki_washida@yahoo.co.jp03-5574-3900

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026